Jeff Castelli, Chief Development Officer at Amicus Therapeutics ($FOLD), sold shares once on the open market in the last year, totaling about $774 thousand. His most recent sale occurred on November 24, 2025. These sales rank 5,487th among 11,678 insiders in our database, where the average is around 8.6 million dollars across roughly 6.4 transactions per insider. Castelli made no open market purchases during this period.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Jan. 3, 2026 | AMICUS THERAPEUTICS, INC. | $FOLD | Castelli Jeff | Chief Development Officer | F | Common Stock | 23102 | $14.27 | 409,311.0000 | 308,533,548 | 5.34% | 0.01% |
| Jan. 2, 2026 | AMICUS THERAPEUTICS, INC. | $FOLD | Castelli Jeff | Chief Development Officer | F | Common Stock | 6905 | $14.27 | 432,413.0000 | 308,533,548 | 1.57% | 0.00% |
| Nov. 24, 2025 | AMICUS THERAPEUTICS, INC. | $FOLD | Castelli Jeff | Chief Development Officer | M | Stock Options (right to buy) | 50000 | $0.00 | 0.0000 | 308,533,548 | 100.00% | 0.02% |
| Nov. 24, 2025 | AMICUS THERAPEUTICS, INC. | $FOLD | Castelli Jeff | Chief Development Officer | M | Common Stock | 50000 | $9.03 | 515,476.0000 | 308,533,548 | 10.74% | 0.02% |
| Nov. 24, 2025 | AMICUS THERAPEUTICS, INC. | $FOLD | Castelli Jeff | Chief Development Officer | S | Common Stock | 76158 | $10.16 | 439,318.0000 | 308,533,548 | 14.77% | 0.02% |
| Feb. 11, 2025 | AMICUS THERAPEUTICS, INC. | $FOLD | Castelli Jeff | Chief Development Officer | A | Common Stock | 52338 | $0.00 | 488,200.0000 | 300,116,081 | 12.01% | 0.02% |
| Feb. 11, 2025 | AMICUS THERAPEUTICS, INC. | $FOLD | Castelli Jeff | Chief Development Officer | F | Common Stock | 22724 | $9.57 | 465,476.0000 | 300,116,081 | 4.65% | 0.01% |
| Jan. 4, 2025 | AMICUS THERAPEUTICS, INC. | $FOLD | Castelli Jeff | Chief Development Officer | F | Common Stock | 3127 | $9.41 | 435,862.0000 | 304,380,502 | 0.71% | 0.00% |
| Jan. 3, 2025 | AMICUS THERAPEUTICS, INC. | $FOLD | Castelli Jeff | Chief Development Officer | A | Stock Options (right to buy) | 150517 | $0.00 | 150,517.0000 | 304,380,502 | 9999.99% | 0.05% |
| Jan. 3, 2025 | AMICUS THERAPEUTICS, INC. | $FOLD | Castelli Jeff | Chief Development Officer | A | Common Stock | 83073 | $0.00 | 453,288.0000 | 304,380,502 | 22.44% | 0.03% |
| Jan. 3, 2025 | AMICUS THERAPEUTICS, INC. | $FOLD | Castelli Jeff | Chief Development Officer | F | Common Stock | 14299 | $9.41 | 438,989.0000 | 304,380,502 | 3.15% | 0.00% |
| Jan. 2, 2025 | AMICUS THERAPEUTICS, INC. | $FOLD | Castelli Jeff | Chief Development Officer | F | Common Stock | 6990 | $9.31 | 370,215.0000 | 304,380,502 | 1.85% | 0.00% |
| Jan. 9, 2024 | AMICUS THERAPEUTICS, INC. | $FOLD | Castelli Jeff | Chief Development Officer | A | Common Stock | 14405 | $0.00 | 387,210.0000 | 295,164,515 | 3.86% | 0.00% |
| Jan. 9, 2024 | AMICUS THERAPEUTICS, INC. | $FOLD | Castelli Jeff | Chief Development Officer | F | Common Stock | 10005 | $13.65 | 377,205.0000 | 295,164,515 | 2.58% | 0.00% |
| Jan. 9, 2024 | AMICUS THERAPEUTICS, INC. | $FOLD | Castelli Jeff | Chief Development Officer | F | Common Stock | 10005 | $13.65 | 362,800.0000 | 295,164,515 | 2.68% | 0.00% |
| Jan. 4, 2024 | AMICUS THERAPEUTICS, INC. | $FOLD | Castelli Jeff | Chief Development Officer | F | Common Stock | 3127 | $13.44 | 372,805.0000 | 295,164,515 | 0.83% | 0.00% |
| Jan. 2, 2024 | AMICUS THERAPEUTICS, INC. | $FOLD | Castelli Jeff | Chief Development Officer | A | Stock Options (right to buy) | 99073 | $0.00 | 99,073.0000 | 295,164,515 | 9999.99% | 0.03% |
| Jan. 2, 2024 | AMICUS THERAPEUTICS, INC. | $FOLD | Castelli Jeff | Chief Development Officer | A | Common Stock | 57392 | $0.00 | 398,053.0000 | 295,164,515 | 16.85% | 0.02% |
| Jan. 2, 2024 | AMICUS THERAPEUTICS, INC. | $FOLD | Castelli Jeff | Chief Development Officer | F | Common Stock | 8038 | $14.24 | 390,015.0000 | 295,164,515 | 2.02% | 0.00% |
| Jan. 3, 2024 | AMICUS THERAPEUTICS, INC. | $FOLD | Castelli Jeff | Chief Development Officer | F | Common Stock | 14083 | $13.53 | 375,932.0000 | 295,164,515 | 3.61% | 0.00% |
| Dec. 28, 2023 | AMICUS THERAPEUTICS, INC. | $FOLD | Castelli Jeff | Chief Development Officer | S | Common Stock | 17421 | $14.52 | 340,661.0000 | 289,057,198 | 4.87% | 0.01% |
| Dec. 18, 2023 | AMICUS THERAPEUTICS, INC. | $FOLD | Castelli Jeff | Chief Development Officer | A | Common Stock | 8643 | $0.00 | 377,236.0000 | 289,057,198 | 2.34% | 0.00% |
| Dec. 19, 2023 | AMICUS THERAPEUTICS, INC. | $FOLD | Castelli Jeff | Chief Development Officer | S | Common Stock | 17500 | $13.25 | 359,736.0000 | 289,057,198 | 4.64% | 0.01% |
| Dec. 20, 2023 | AMICUS THERAPEUTICS, INC. | $FOLD | Castelli Jeff | Chief Development Officer | S | Common Stock | 1654 | $13.10 | 358,082.0000 | 289,057,198 | 0.46% | 0.00% |
| Aug. 17, 2023 | AMICUS THERAPEUTICS, INC. | $FOLD | Castelli Jeff | Chief Development Officer | F | Common Stock | 14560 | $12.77 | 368,593.0000 | 289,057,198 | 3.80% | 0.01% |
| Jan. 11, 2023 | AMICUS THERAPEUTICS, INC. | $FOLD | Castelli Jeff | Chief Development Officer | F | Common Stock | 24325 | $12.02 | 383,153.0000 | 289,057,198 | 5.97% | 0.01% |
| Jan. 11, 2023 | AMICUS THERAPEUTICS, INC. | $FOLD | Castelli Jeff | Chief Development Officer | A | Common Stock | 56024 | $0.00 | 407,478.0000 | 289,057,198 | 15.94% | 0.02% |
| Jan. 4, 2023 | AMICUS THERAPEUTICS, INC. | $FOLD | Castelli Jeff | Chief Development Officer | F | Common Stock | 3127 | $12.03 | 351,454.0000 | 289,057,198 | 0.88% | 0.00% |
| Jan. 3, 2023 | AMICUS THERAPEUTICS, INC. | $FOLD | Castelli Jeff | Chief Development Officer | F | Common Stock | 6411 | $11.93 | 354,581.0000 | 289,057,198 | 1.78% | 0.00% |
| Jan. 3, 2023 | AMICUS THERAPEUTICS, INC. | $FOLD | Castelli Jeff | Chief Development Officer | A | Common Stock | 70681 | $0.00 | 360,992.0000 | 289,057,198 | 24.35% | 0.02% |
| Jan. 2, 2023 | AMICUS THERAPEUTICS, INC. | $FOLD | Castelli Jeff | Chief Development Officer | F | Common Stock | 13944 | $12.21 | 290,311.0000 | 289,057,198 | 4.58% | 0.00% |
| Jan. 3, 2023 | AMICUS THERAPEUTICS, INC. | $FOLD | Castelli Jeff | Chief Development Officer | A | Stock Options (right to buy) | 125462 | $0.00 | 125,462.0000 | 289,057,198 | 9999.99% | 0.04% |